Discovery of LY2607540: A novel and selective mGluR2 positive allosteric modulator (PAM) demonstrates activity in animal models of anxiety and depression

被引：0
|
作者：
Khilevich, Albert [1 ]
Mayhugh, Daniel R. [1 ]
Hay, David A. [1 ]
Zhang, Deyi [1 ]
Liu, Bin [1 ]
Svensson, Kjell A. [1 ]
Falcone, Julie F. [1 ]
Heinz, Beverly A. [1 ]
Wang, Xushan [1 ]
Witkin, Jeff M. [1 ]
Rassmussen, Kurt [1 ]
Rorick-Kehn, Linda [1 ]
Benvenga, Mark J. [1 ]
Li, Xia [1 ]
Hart, John C. [1 ]
Chaney, Stephen [1 ]
Catlow, John T. [1 ]
Swanson, Steve [1 ]
Schkeryantz, Jeffrey M. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
87-MEDI
引用
收藏
页数：1
相关论文
共 31 条
  • [21] Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype
    Temple, Kayla J.
    Engers, Julie L.
    Long, Madeline F.
    Watson, Katherine J.
    Chang, Sichen
    Luscombe, Vincent B.
    Jenkins, Matthew T.
    Rodriguez, Alice L.
    Niswender, Colleen M.
    Bridges, Thomas M.
    Conn, P. Jeffrey
    Engers, Darren W.
    Lindsley, Craig W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (03)
  • [22] LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization
    Verma, Mahip K.
    Goel, Rajan N.
    Bokare, Anand M.
    Dandekar, Manoj P.
    Koul, Sarita
    Desai, Sagar
    Tota, Santoshkumar
    Singh, Nilendra
    Nigade, Prashant B.
    Patil, Vinod B.
    Modi, Dipak
    Mehta, Maneesh
    Gundu, Jayasagar
    Walunj, Sameer S.
    Karche, Navnath P.
    Sinha, Neelima
    Kamboj, Rajender K.
    Palle, Venkata P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
  • [23] A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
    Kinney, GG
    O'Brien, JA
    Lemaire, W
    Burno, M
    Bickel, DJ
    Clements, MK
    Chen, TB
    Wisnoski, DD
    Lindsley, CW
    Tiller, PR
    Smith, S
    Jacobson, MA
    Sur, C
    Duggan, ME
    Pettibone, DJ
    Conn, PJ
    Williams, DL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01): : 199 - 206
  • [24] Characterization of the Novel M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Vu0467154 in Animal Models of Antipsychotic- like Activity, Cognitive Enhancement and Changes in Sleepwake Architecture
    Jones, Carrie K.
    Bridges, Thomas M.
    Bubser, Michael
    Gould, Robert W.
    Thorbek, Ditte Dencker
    Grannan, Michael D.
    Daniels, J. Scott
    Noetzel, Meredith J.
    Niswender, Colleen M.
    Duggan, Mark E.
    Brandon, Nicholas J.
    Dunlop, John
    Wood, Michael W.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S575 - S576
  • [25] Identification and Characterization of ML321: A Novel and Highly Selective D2 Dopamine Receptor Antagonist That Demonstrates Efficacy in Animal Models That Predict Antipsychotic Activity
    Sibley, David
    Free, R. Benjamin
    Xiao, Jingbo
    Ferrer, Marc
    Southall, Noel
    Javitch, Jonathan
    Mach, Robert
    Bertz, Jeremiah
    Shi, Lei
    Woods, James
    Marugan, Juan
    Wetsel, William C.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S243 - S244
  • [26] Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
    Salovich, James M.
    Vinson, Paige N.
    Sheffler, Douglas J.
    Lamsal, Atin
    Utley, Thomas J.
    Blobaum, Anna L.
    Bridges, Thomas M.
    Le, Uyen
    Jones, Carrie K.
    Wood, Michael R.
    Daniels, J. Scott
    Conn, P. Jeffrey
    Niswender, Colleen M.
    Lindsley, Craig W.
    Hopkins, Corey R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 5084 - 5088
  • [27] Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)
    Maria Cid, Jose
    Tresadern, Gary
    Antonio Vega, Juan
    Isabel de Lucas, Ana
    del Cerro, Alcira
    Matesanz, Encamacion
    Lourdes Linares, Maria
    Garcia, Aranzazu
    Ituttrino, Laura
    Perez-Benito, Laura
    Macdonald, Gregor J.
    Oehlrich, Daniel
    Lavreysen, Hilde
    Peeters, Luc
    Ceusters, Marc
    Ahnaou, Abdellah
    Drinkenburg, Wilhelmus
    Mackie, Claire
    Somers, Marijke
    Trabanco, Andres A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8495 - 8507
  • [28] Discovery, Synthesis, and Structure-Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model
    Jones, Carrie K.
    Engers, Darren W.
    Thompson, Analisa D.
    Field, Julie R.
    Blobaum, Anna L.
    Lindsley, Stacey R.
    Zhou, Ya
    Gogliotti, Rocco D.
    Jadhav, Satyawan
    Zamorano, Rocio
    Bogenpohl, Jim
    Smith, Yoland
    Morrison, Ryan
    Daniels, J. Scott
    Weaver, C. David
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Niswender, Colleen M.
    Hopkins, Corey R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) : 7639 - 7647
  • [29] Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization
    Sinha, Neelima
    Karche, Navnath P.
    Verma, Mahip Kalyan
    Walunj, Sameer S.
    Nigade, Prashant B.
    Jana, Gourhari
    Kurhade, Sanjay P.
    Hajare, Anil K.
    Tilekar, Ajay R.
    Jadhav, Ganesh R.
    Thube, Baban R.
    Shaikh, Javed S.
    Balgude, Sudhakar
    Singh, Lairikyengbam Bikramjit
    Mahimane, Vijaya
    Adurkar, Shridhar K.
    Hatnapure, Girish
    Raje, Firoj
    Bhosale, Yogesh
    Bhanage, Dnyaneshwar
    Sachchidanand, Sachchidanand
    Dixit, Ruchi
    Gupta, Rajesh
    Bokare, Anand M.
    Dandekar, Manoj
    Bharne, Ashish
    Chatterjee, Manavi
    Desai, Sagar
    Koul, Sarita
    Modi, Dipak
    Mehta, Maneesh
    Patil, Vinod
    Singh, Minakshi
    Gundu, Jayasagar
    Goel, Rajan N.
    Shah, Chirag
    Sharma, Sharad
    Bakhle, Dhananjay
    Kamboj, Rajender Kumar
    Palle, Venkata P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) : 944 - 960
  • [30] Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain
    Munro, G.
    Lopez-Garcia, J. A.
    Rivera-Arconada, I.
    Erichsen, H. K.
    Nielsen, E. O.
    Larsen, J. S.
    Ahring, P. K.
    Mirza, N. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (03): : 969 - 981
1234